Lisinopril and Hydrochlorothiazide

Product NDC
60760-968
11-digit product format
607600968
Labeler code
60760
Product ID
60760-968_cb6a684f-7f11-89df-e053-2a95a90acdee
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Lisinopril and Hydrochlorothiazide Tablets
Dosage form
TABLET
Route
ORAL
Labeler
St. Mary's Medical Park Pharmacy
Application
ANDA204058
Marketing category
ANDA
Marketing start
2021-09-07
Marketing end
0000-00-00
Substance
LISINOPRIL; HYDROCHLOROTHIAZIDE
Active strength
10 mg/1; mg/1
Pharmacologic classes
Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS],Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
60760-968LISINOPRIL AND HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS) TABLET [ST. MARY'S MEDICAL PARK PHARMACY]1Legacy NDC20210923_cb6a5f8e-9573-1d8b-e053-2a95a90a384e.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
60760-968-906076009689090 TABLET in 1 BOTTLE, PLASTIC (60760-968-90) 90 tablet2021-09-070000-00-00NoNoCurrent